In this webinar, discover how advanced techniques such as Al-driven candidate selection optimization of antibody sequences, and precise conjugation methods come together to address some of the current challenges in antibody-based therapeutics.

Some things you’ll learn include:

Antibody Engineering with Zymeworks: Learn about how we push the boundary of antibody engineering by optimizing antibody sequences to develop the next generation of antibody-based therapeutics, including antibody-drug conjugates.

Strategic Al-based Antibody Selection with Aureka Bio: Learn about how Al can accelerate the selection, synthesis, and characterization of antibody candidates at scale during therapeutic discovery.

Precision in Antibody Conjugation with ACROBiosystems: Discover how ACROBiosystems can transform your antibodies into antibody-drug conjugates with various life science tools to conjugate and characterize your ADC.